COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis
NCT: NCT05035823 · ACTIVE_NOT_RECRUITING
Brief Summary
The Synchron motor neuroprosthesis (MNP) is intended to be used in subjects with severe motor impairment, unresponsive to medical or rehabilitative therapy and a persistent functioning motor cortex. The purpose of this research is to evaluate safety and feasibility. The MNP is a type of implantable brain computer interface which bypasses dysfunctional motor neurons. The device is designed to restore the transmission of neural signal from the cerebral cortex utilized for neuromuscular control of digital devices, resulting in a successful execution of non-mechanical digital commands.
Frequently Asked Questions
What is COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis?
COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis is a clinical trial registered under NCT05035823. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05035823?
The current status of NCT05035823 (COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis) is: ACTIVE_NOT_RECRUITING.
When did COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis start?
COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis started on 2022-04-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.